Barclays downgraded Doximity (DOCS) to Equal Weight from Overweight with a price target of $20, down from $38. Growth in the digital advertising space is slowing while competition is ramping, the analyst tells investors in a research note. As such, Barclays expects industry growth to remain “lackluster,” keeping shares of Doximity and Phreesia range-bound. Digital marketing industry players have been reporting slower growth in the past couple of quarters, the firm says. It sees no sign of this easing.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DOCS:
